Fixed Income

Credit hedges for Brexit

  • 15 June 2016
  • 3min read

CDS indices and CDS index options to the rescue

Ahead of the UK’s EU referendum, Greg Venizelos presents some hedging options for credit investors who may wish to protect their portfolios from downside risks in case of a ‘leave’ outcome.

We would like to acknowledge the valuable contribution of Amaury Boyenval (Solutions & Structuring Group) and Frederic Suhit (Derivatives Management Team).

The most simple protection for a credit portfolio against widening spreads is to reduce exposures, either by selling holdings or by hedging some credit risk via credit default swaps (CDS). Investors who may wish to retain a more asymmetric risk/reward profile by keeping the potential upside while protecting the downside, can employ CDS option instruments (swaptions). These can present attractive strategies that either reduce the cost of hedging or provide a proxy portfolio hedge at a macro level when other ‘vanilla’ hedges are unavailable. For euro credit the derivatives market is relatively deep, meaning investors can find reasonable levels of liquidity in terms of significant transaction size, reasonably narrow bid-offer spread and limited execution delay. The instruments in question are single-name CDS, CDS indices or CDS index options (eg in iTraxx). Today, euro credit investors can hedge a credit portfolio of 5-year maturity by buying protection in the iTraxx Main 5y CDS index, at an annual cost of 85bps vs a portfolio spread annual income of 90bps. Following the event being hedged and the associated repricing in risk premia, investors could unwind the hedge at a wider spread than what they paid for protection, and crystalise the mark to market gains. This will offset some or all of the adverse valuation impact on their cash portfolio. Euro investors could also explore the use of CDS swaptions to benefit from a potential spread widening in euro credit in a more cost efficient way. In their simplest form, swaption strategies may involve the purchase of outright payers (buying a put on a CDS index), which gain increasingly in mark to market terms above their strike price, once the option premium has been recouped. Investors who believe that spread widening will be capped (say due to the Corporate Sector Purchase Programme backstop) can reduce the cost of their hedge by selling a payer at a wider strike (selling a put further out of the money). In such a strategy, mark to market gains level out if spreads widen beyond the wider strike, as further gains on the long payer are offset by losses on the short payer. Exhibit 1 shows indicative pricing information for some typical payer and payer spread strategies with July and September expiries.

    Not for Retail distribution:

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date.

    All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.

    Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales, No: 01431068. Registered Office: 22 Bishopsgate, London, EC2N 4BQ. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.